Alzheimer's Disease & Related Dementias Research Day 2023

Registration For ADRD 2023 Is Now Closed!

Monday, April 17, 2023, 10 a.m.-3:30 p.m.

Discovery Building and via Live Stream

The annual Alzheimer's Disease & Related Dementias Research Day is hosted by the Wisconsin Alzheimer’s Disease Research Center. It is designed to encourage collaboration and promote scientific thought among faculty, students and researchers from a wide range of disciplines across the UW—Madison campus. We invite UW—Madison students, scientists and researchers from all areas to join us and learn about the amazing work being done on campus.

Our Featured Speakers

Headshots of Henrik Zetterberg, Crystal Glover, and Catherine Gallagher

 From left to right: Henrik Zetterberg, MD, PhD; Crystal Glover, PhD; Catherine Gallagher, MD

Learn more about Henrik Zetterberg, MD, PhD

Henrik Zetterberg is a Professor of Neurochemistry at the University of Gothenburg, Sweden, and University College London, UK, and a Clinical Chemist at Sahlgrenska University Hospital in Gothenburg, Sweden. He is Head of the Department of Psychiatry and Neurochemistry at the University of Gothenburg, leads the UK DRI Fluid Biomarker Laboratory at UCL, and is a Key Member of the Hong Kong Center for Neurodegenerative Diseases and a Visiting Professor in the UW Department of Medicine, School of Medicine and Public Health, Madison, Wisconsin. His main research focus and clinical interest are fluid biomarkers for brain diseases, neurodegenerative diseases in particular.

Dr. Zetterberg's talk, "The latest developments in the neurodegenerative disease fluid biomarker field," will happen at 10:05 a.m. on April 17.

Learn more about Crystal Glover, PhD

Crystal M. Glover, Ph.D. is an applied social psychologist, mixed methodologist, and health equity in aging researcher at the Rush Alzheimer’s Disease Center and an Associate Professor of Psychiatry and Behavioral Sciences (and) Neurological Sciences in Rush Medical College. She also leads the Outreach, Recruitment, and Engagement Core at the Rush Alzheimer’s Disease Center. Dr. Glover’s areas of interest include health equity and health disparities; structural and psychosocial determinants of health including socioeconomic status and psychological wellbeing; intersectionality as a conceptual framework and methodology; and social cognitive processes such as attitudes, beliefs, and perceptions. She focuses her research and related efforts on understanding and facilitating cognitive and healthy aging across all demographic groups but with a special concentration on collaborating with and inclusion of members of African American/Black and Hispanic/Latino communities that have been inequitably included and traditionally understudied in aging research. She has widely published her peer-reviewed work in several high-impact scientific journals, including Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association, CHEST, and Human Genetics. She continues to present her research at international and national scientific meetings, and belongs to several professional groups, including The Alzheimer’s Association International Society To Advance Alzheimer’s Research and Treatment (ISTAART) and the Centers for Disease Control and Prevention BOLD Public Health Center of Excellence on Dementia Risk Reduction. Overall, Dr. Glover dedicates her work to eradicating health disparities and creating health equity - globally, nationally, and locally.

Dr. Glover's talk, “Examining Diverse Participant Perspectives and Incorporating Resultant Strategies to Advance Dementia Biomarker Research," will happen at 1:20 p.m. on April 17.

Learn more about Catherine Gallagher, MD

Dr. Gallagher is a movement disorders specialist, providing care for patients with Parkinson's disease as well as other neurodegenerative disorders. Her primary research interest is the development and use of brain imaging biomarkers in Parkinson's disease, Alzheimer's disease, and related neurodegenerative disorders. Her research program has been funded through national VA grants since 2007. Her current studies aim to identify preclinical markers for Parkinson's disease in Veterans with sleep disorders. She also enjoys many productive collaborations with the Wisconsin ADRC, which are focused on the detection and modification of Alzheimer's disease risk.

Dr. Gallagher's talk, "Finding Parkinson's before it starts," will happen at 1:55 p.m. on April 17.


Presentations will be in the H.F. DeLuca Forum. The Poster Session will be in the Open Court.

9:30 a.m. — Registration/Sign in
10:00 a.m. — Opening Remarks from Barbara Bendlin, PhD, and Robert Golden, MD, Dean of the University of Wisconsin School of Medicine and Public Health
10:05 a.m. — Featured Speaker: Henrik Zetterberg, MD, PhD, Professor of Neurochemistry at the University of Gothenburg, Sweden, and University College London, UK — “The latest developments in the neurodegenerative disease fluid biomarker field”
10:35 a.m. — Bagel and Coffee Break
10:45 a.m. — Presentation of Neuroscience Next Awards (Please register for the Alzheimer’s Association Neuroscience Next 2023 if you would like to participate in this portion of the event)
11:30 a.m. — Poster Session in the Open Court

12:45 p.m. — Lunch in the DeLuca Forum
1:10 p.m. — ADRC Update from Sanjay Asthana, MD
1:20 p.m. — Featured Speaker: Crystal M. Glover, PhD, Associate Professor, Division of Behavioral Sciences, RUSH Medical College, Social Psychologist, Rush Alzheimer's Disease Center — “Examining Diverse Participant Perspectives and Incorporating Resultant Strategies to Advance Dementia Biomarker Research
1:55 p.m. — Featured Speaker: Catherine Gallagher, MD, Professor of Neurology, University of Wisconsin School of Medicine and Public Health, Chief of Neurology, William S. Middleton Memorial Veterans Hospital — "Finding Parkinson's before it starts"
2:25 p.m. — Lightning Presentations in the H.F. DeLuca Forum

Our 2023 Lightning Presenters

•    Karly A. Cody, PhD Student Neuroscience Training Program, Johnson Lab, “Rates of tau PET accumulation along the amyloid timeline in Alzheimer's disease”
•    Meghan Haas, MSW, APSW, Gilmore-Bykovskyi Lab, “Brain Health Community Registry: Development and preliminary evaluation of a model for connecting research participants to community-based services and supports”
•    Taryn T. James, PhD, Gleason Lab, “Disseminating COVID-19 and Alzheimer's Disease Information to Underrepresented Communities Using Social Media”
•    Kaitlyn M. Marino, BS, PhD Candidate Neuroscience Training Program, Tyler Ulland Lab, “Assessing the metabolic response of microglia to amyloid deposition in a mouse model of Alzheimer’s disease”
•    Jose L. Martinez, BS, MPA, MS, Bhattacharyya Lab, “A Human Stem Cell Model of Basal Forebrain Cholinergic Neurons” 
•    Jason F. Moody, PhD, Bendlin Lab, “Staging Neurodegeneration Across the Alzheimer's Disease Continuum”
•    Kylie Ruprecht, undergraduate student, Carlsson Lab, “Association of Potential Risk Factors with Cognition and Hippocampal Volume in Veterans”
•    Lauren Sarko, Ph.D. Candidate, Cellular and Molecular Pathology, Saha Lab, “CRISPR-Edited, Chimeric Antigen Receptor (CAR) T Cells to Target Senescence in Neurodegeneration”

3:10 p.m. — Presentation of Awards
3:30 p.m. — Close of Event